Characterisation of tumour vasculature in mouse brain by USPIO contrast-enhanced MRI

British Journal of Cancer

Volumn 98, Issue 11, 2008, Pages 1784-1789

  Gambarota, G ^a,c   Leenders, W ^a   Maass, C ^a   Wesseling, P ^a   Van Der Kogel, B ^a   Van Tellingen, O ^b   Heerschap, A ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

^c EPFL   (Switzerland)

Author keywords

Contrast agent; Gd DTPA; High field MR; Mouse brain; Tumour; USPIO; VEGF

Indexed keywords

GADOLINIUM PENTETATE; IRON OXIDE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BLOOD VOLUME; BRAIN TUMOR; CONTRAST ENHANCEMENT; CONTROLLED STUDY; GLIOBLASTOMA; IMMUNOHISTOCHEMISTRY; MELANOMA; MEMBRANE PERMEABILITY; METASTASIS; MICROVASCULATURE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIODIAGNOSIS; VASCULAR TUMOR; XENOGRAFT;

ANIMALS; BLOOD VOLUME; BRAIN NEOPLASMS; CAPILLARY PERMEABILITY; CONTRAST MEDIA; GADOLINIUM DTPA; GLIOMA; HUMANS; IMAGE ENHANCEMENT; IRON; MAGNETIC RESONANCE IMAGING; MELANOMA, EXPERIMENTAL; MICE; NEOPLASM TRANSPLANTATION; OXIDES; TRANSPLANTATION, HETEROLOGOUS;

EID: 44349168211     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6604389     Document Type: Article

References (25)

1. Bremer C, Mustafa M, Bogdanov Jr A, Ntziachristos V, Petrovsky A, Weissleder R (2003) Steady-state blood volume measurements in experimental tumors with different angiogenic burdens a study in mice. Radiology 226: 214-206
2. Claes A, Gambarota G, Hamans B, van Tellingen O, Wesseling P, Maass C, Heerschap A, Leenders W (2008) Magnetic resonance imaging-based detection of glial brain tumors in mice after antiangiogenic treatment. Int J Cancer 122(9): 1981-1986
3. Dennie J, Mandeville JB, Boxerman JL, Packard SD, Rosen BR, Weisskoff RM (1998) NMR imaging of changes in vascular morphology due to tumor angiogenesis. Magn Reson Med 40: 793-799
4. Enochs WS, Harsh G, Hochberg F, Weissleder R (1999) Improved delineation of human brain tumors on MR images using a long-circulating, superparamagnetic iron oxide agent. J Magn Reson Imaging 9: 228-232
5. Folkman J (1992) The role of angiogenesis in tumor growth. Semin Cancer Biol 3: 65-71
6. Gambarota G, van Laarhoven HW, Philippens M, Lok J, van der Kogel A, Punt CJ, Heerschap A (2006) Assessment of absolute blood volume in carcinoma by USPIO contrast-enhanced MRI. Magn Reson Imaging 24: 279-286
7. Harisinghani MG, Barentsz J, Hahn PF, Deserno WM, Tabatabaei S, van de Kaa CH, de la Rosette J, Weissleder R (2003) Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 348: 2491-2499
8. Kennan RP, Zhong J, Gore JC (1994) Intravascular susceptibility contrast mechanisms in tissues. Magn Reson Med 31: 9-21
9. Kusters B, Leenders WP, Wesseling P, Smits D, Verrijp K, Ruiter DJ, Peters JP, van Der Kogel AJ, de Waal RM (2002) Vascular endothelial growth factor-A(165) induces progression of melanoma brain metastases without induction of sprouting angiogenesis. Cancer Res 62: 341-345
10. Kusters B, Westphal JR, Smits D, Ruiter DJ, Wesseling P, Keilholz U, de Waal RM (2001) The pattern of metastasis of human melanoma to the central nervous system is not influenced by integrin alpha(v)beta(3) expression. Int J Cancer 92: 176-180
11. Le Duc G, Peoc'h M, Remy C, Charpy O, Muller RN, Le Bas JF, Decorps M (1999) Use of T2-weighted susceptibility contrast MRI for mapping the blood volume in the glioma-bearing rat brain. Magn Reson Med 42: 754-761
12. Leenders W, Kusters B, Pikkemaat J, Wesseling P, Ruiter D, Heerschap A, Barentsz J, de Waal RM (2003) Vascular endothelial growth factor-A determines detectability of experimental melanoma brain metastasis in GD-DTPA-enhanced MRI. Int J Cancer 105: 437-443
13. Leenders WP, Kusters B, Verrijp K, Maass C, Wesseling P, Heerschap A, Ruiter D, Ryan A, de Waal R (2004) Antiangiogenic therapy of cerebral melanoma metastases results in sustained tumor progression via vessel co-option. Clin Cancer Res 10: 6222-6230
14. Pathak AP, Rand SD, Schmainda KM (2003) The effect of brain tumor angiogenesis on the in vivo relationship between the gradient-echo relaxation rate change (DeltaR2*) and contrast agent (MION) dose. J Magn Reson Imaging 18: 397-403
15. Pirzkall A, McKnight TR, Graves EE, Carol MP, Sneed PK, Wara WW, Nelson SJ, Verhey LJ, Larson DA (2001) MR-spectroscopy guided target delineation for high-grade gliomas. Int J Radiat Oncol Biol Phys 50: 915-928
16. Robinson SP, Rijken PF, Howe FA, McSheehy PM, Van Der Sanden BP, Heerschap A, Stubbs M, Van Der Kogel AJ, Griffiths JR (2003) Tumor vascular architecture and function evaluated by non-invasive susceptibility MRI methods and immunohistochemistry. J Magn Reson Imaging 17: 445-454
17. Stadlbauer A, Moser E, Gruber S, Buslei R, Nimsky C, Fahlbusch R, Ganslandt O (2004) Improved delineation of brain tumors: an automated method for segmentation based on pathologic changes of 1H-MRSI metabolites in gliomas. Neuroimage 23: 454-461
18. Su MY, Muhler A, Lao X, Nalcioglu O (1998) Tumor characterization with dynamic contrast-enhanced MRI using MR contrast agents of various molecular weights. Magn Reson Med 39: 259-269
19. Taschner CA, Wetzel SG, Tolnay M, Froehlich J, Merlo A, Radue EW (2005) Characteristics of ultrasmall superparamagnetic iron oxides in patients with brain tumors. AJR Am J Roentgenol 185: 1477-1486
20. Tropres I, Grimault S, Vaeth A, Grillon E, Julien C, Payen JF, Lamalle L, Decorps M (2001) Vessel size imaging. Magn Reson Med 45: 397-408
21. Turetschek K, Roberts TP, Floyd E, Preda A, Novikov V, Shames DM, Carter WO, Brasch RC (2001) Tumor microvascular characterization using ultrasmall superparamagnetic iron oxide particles (USPIO) in an experimental breast cancer model. J Magn Reson Imaging 13: 882-888
22. van Laarhoven HW, Gambarota G, Lok J, Lammens M, Kamm YL, Wagener T, Punt CJ, van der Kogel AJ, Heerschap A (2006) Carbogen breathing differentially enhances blood plasma volume and 5-fluorouracil uptake in two murine colon tumor models with a distinct vascular structure. Neoplasia 8: 477-487
23. Varallyay P, Nesbit G, Muldoon LL, Nixon RR, Delashaw J, Cohen JI, Petrillo A, Rink D, Neuwelt EA (2002) Comparison of two superparamagnetic viral-sized iron oxide particles ferumoxides and ferumoxtran-10 with a gadolinium chelate in imaging intracranial tumors. AJNR Am J Neuroradiol 23: 510-519
24. Verhoye M, van der Sanden BP, Rijken PF, Peters HP, Van der Kogel AJ, Pee G, Vanhoutte G, Heerschap A, Van der Linden A (2002) Assessment of the neovascular permeability in glioma xenografts by dynamic T1 MRI with Gadomer-17. Magn Reson Med 47: 305-313
25. Weisskoff RM, Zuo CS, Boxerman JL, Rosen BR (1994) Microscopic susceptibility variation and transverse relaxation: theory and experiment. Magn Reson Med 31: 601-610